Abstract
Vancomycin is a commonly used antimicrobial in hospitals, and therapeutic drug monitoring (TDM) is required to optimize its efficacy and avoid toxicities. Bayesian models are currently recommended to predict the antibiotic levels. These models, however, although using carefully designed lab observations, were often developed in limited patient populations. The increasing availability of electronic health record (EHR) data offers an opportunity to develop TDM models for real-world patient populations. Here, we present a deep learning-based pharmacokinetic prediction model for vancomycin (PK-RNN-V E) using a large EHR dataset of 5,483 patients with 55,336 vancomycin administrations. PK-RNN-V E takes the patient’s real-time sparse and irregular observations and offers dynamic predictions. Our results show that RNN-PK-V E offers a root mean squared error (RMSE) of 5.39 and outperforms the traditional Bayesian model (VTDM model) with an RMSE of 6.29. We believe that PK-RNN-V E can provide a pharmacokinetic model for vancomycin and other antimicrobials that require TDM.
Problem Current traditional Bayesian models for vancomycin levels were tested in only a limited patient population and take limited patient-specific features. Hence, a more flexible and powerful model, such as deep-learning models, may provide significant advantages.
What is Already Known The Bayesian models do not predict the vancomycin levels well in patient populations with unstable hemodynamic status and fluctuating kidney functions.
What this Paper Adds Deep-learning based pharmacokinetic model for vancomycin (PK-RNN-V E) provided better prediction accuracy with integrating multiple patient-specific features from time sequence electronic health record data. This study proved the concept of model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of The University of Texas Health Science Center at Houston approved this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- AI
- Artificial intelligence
- ACE
- Angiotensin
- ASHP
- American Society of Health-System Pharmacists
- AUC
- Area Under the Curve
- BMI
- Body Mass Index
- CKD
- Chronic Kidney Disease
- DHHS
- U.S. Department of Health and Human Services
- DM
- Diabetes Mellitus
- ECMO
- Extracorporeal Membrane Oxygenation
- EHR
- Electronic Health Record
- HTN
- Hypertension
- ICU
- Intensive Care Unit
- IDSA
- Infectious Diseases Society of America
- IQR
- Interquartile Range
- IRB
- Internal Review Boards
- MAE
- Mean Absolute Error
- MAPE
- Mean Absolute Percentage Error
- MHHS
- Memorial Hermann Health System
- MIC
- Minimal Inhibitory Concentration
- MRSA
- Methicillin resistant Staphylococcus aureus
- SIDP
- Society for Infectious Diseases Pharmacists
- TDM
- Therapeutic Drug Monitoring
- PK
- Pharmacokinetic
- RMSE
- Root Mean Square Error
- RNN
- Recurrent Neural Network
- VAN
- Vancomycin
- VTDM
- Vancomycin Therapeutic Drug Monitoring